Anti-tumour activity of afatinib, an irreversible ErbB family blocker, in human pancreatic tumour cells

por Ioannou, N, Dalgleish, A G, Seddon, A M, Mackintosh, D, Guertler, U, Solca, F, Modjtahedi, H
Publicado 2011